Latest Period
Q4 2025
Security Snapshot
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) Institutional Ownership
CUSIP: 56270V205
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
18
Shares (Excl. Options)
2,537,025
Price
$0.74
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- MGRX on Nasdaq
- Shares outstanding
- 14,002,438
- Price per share
- $0.39
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 2,537,025
- Total reported value
- $1,877,635
- % of total 13F portfolios
- 0%
- Share change
- +2,162,467
- Value change
- +$1,555,416
- Number of holders
- 18
- Price from insider filings
- $0.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share is tracked under CUSIP 56270V205.
- 18 institutions reported positions in Q4 2025.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 18 to 2 between Q4 2025 and Q1 2026.
- Reported value moved from $1,877,635 to $4,085.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 18 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 56270V205?
CUSIP 56270V205 identifies MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 56270V205:
Significant Owners of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cohen Jacob D. | 15% | +33% | $4,599,801 | +$2,526,052 | 2,044,356 | +122% | Jacob D. Cohen | 21 Jul 2025 |
| GREENFIELD INVESTMENTS LTD. | 14% | $916,700 | 515,000 | Greenfield Investments, Ltd | 13 Dec 2024 |
As of 31 Dec 2025, 18 institutional investors reported holding 2,537,025 shares of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX). This represents 18% of the company’s total 14,002,438 outstanding shares.
Top 21 Institutional Shareholders
The largest institutional shareholders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11% | 1,536,000 | 0.03% | $1,136,640 | |
| VANGUARD GROUP INC | 3.5% | 489,532 | +155% | 0% | $362,254 |
| Ikarian Capital, LLC | 0.99% | 138,146 | 0.01% | $102,229 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | 108,322 | +23% | 0% | $80,157 |
| JANE STREET GROUP, LLC | 0.34% | 47,503 | 0% | $35,152 | |
| UBS Group AG | 0.33% | 46,167 | +1538800% | 0% | $34,164 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.27% | 38,441 | 0% | $28,446 | |
| NORTHERN TRUST CORP | 0.27% | 37,579 | +98% | 0% | $27,808 |
| Ackerman Capital Advisors, LLC | 0.25% | 34,500 | 0% | 0.01% | $25,530 |
| Virtu Financial LLC | 0.24% | 33,462 | 0% | $25,000 | |
| Sunbelt Securities, Inc. | 0.09% | 12,000 | +71% | 0% | $8,880 |
| Csenge Advisory Group | 0.07% | 10,000 | 0% | $7,400 | |
| OSAIC HOLDINGS, INC. | 0.02% | 2,885 | 0% | 0% | $2,134 |
| Tower Research Capital LLC (TRC) | 0.01% | 1,002 | 0% | $741 | |
| MORGAN STANLEY | 0.01% | 1,000 | 0% | $740 | |
| Fortitude Family Office, LLC | 0% | 378 | 0% | $280 | |
| BANK OF AMERICA CORP /DE/ | 0% | 107 | -39% | 0% | $79 |
| CITIGROUP INC | 0% | 1 | 0% | $1 | |
| Steward Partners Investment Advisory, LLC | 0% | 0 | -100% | $0 | |
| ROYAL BANK OF CANADA | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 |
Institutional Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 11,343 | $4,085 | +$348 | $0.36 | 2 |
| 2025 Q4 | 2,537,025 | $1,877,635 | +$1,555,416 | $0.74 | 18 |
| 2025 Q3 | 374,558 | $820,064 | +$209,344 | $2.19 | 11 |
| 2025 Q2 | 292,252 | $444,221 | +$326,694 | $1.52 | 10 |
| 2025 Q1 | 75,317 | $146,866 | -$46,995 | $1.95 | 8 |
| 2024 Q4 | 91,338 | $220,943 | +$216,913 | $2.42 | 9 |
| 2024 Q3 | 17,077 | $4,030 | +$4,030 | $0.24 | 1 |